LF 070165C

Drug Profile

LF 070165C

Alternative Names: LF 70165C

Latest Information Update: 22 Oct 1997

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Groupe Fournier
  • Class Antihyperlipidaemics; Sterols
  • Mechanism of Action Cholesterol inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Hypercholesterolaemia

Most Recent Events

  • 22 Oct 1997 Discontinued-Preclinical for Hypercholesterolaemia in France (Unknown route)
  • 23 Jun 1995 Preclinical development for Hypercholesterolaemia in France (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top